Cardiovascular Risk Profile and Antihypertensive Treatment

Cardiovascular Risk Profile and Antihypertensive Treatment

Blood pressure–lowering treatment reduces cardiovascula risk. However, individuals treated with antihypertensive medication had primarily worse prognosis for cardiovascular diseases than untreated hypertensive or normotensive population. Although the strong positive relationship between blood pressure level and cardiovascular disease risks were observed among general population, there is little argument as to the risk increase with elevation of blood pressure among treated participants.

 

    Related Conference of Cardiovascular Risk Profile and Antihypertensive Treatment

    July 27-28, 2026

    12th International Heart Conference

    Dubai, UAE
    July 29-30, 2026

    30th World Cardiology Conference

    Paris, France
    August 17-18, 2026

    4th International Conference on World Heart Care

    Toronto, Canada
    August 27-28, 2026

    40th European Cardiology Conference

    Berlin, Germany
    October 20-21, 2026

    15th World Heart Congress

    London, UK
    November 09-10, 2026

    7th Annual Summit on Cardiology and Heart Diseases

    Paris, France
    November 16-17, 2026

    8th World Heart Congress

    Tokyo, Japan
    November 16-17, 2026

    5th Global Summit on Cardiology and Cardiac Surgery

    Tokyo, Japan
    November 23-24, 2026

    40th World Congress on Heart Diseases

    Toronto, Canada
    November 25-26, 2026

    33rd World Heartcare Summit

    Paris, France
    March 18-19, 2027

    16th World Heart Congress

    Paris, France